Passa al contenuto
Merck

Vai a

E7284

EPHA2 (561-end), active, GST tagged human

PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution

Sinonimo/i:

ECK

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Voi/SKUDisponibilitàPrezzo
10 μg
Per informazioni sulla disponibilità, contatta il Servizio Clienti.
385,00 €

Informazioni su questo articolo

NACRES:
NA.32
UNSPSC Code:
12352200
Specific activity:
74-102 nmol/min·mg
Assay:
≥70% (SDS-PAGE)
Recombinant:
expressed in baculovirus infected Sf9 cells

385,00 €


Per informazioni sulla disponibilità, contatta il Servizio Clienti.

​
Richiedi un ordine personalizzato
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


recombinant

expressed in baculovirus infected Sf9 cells

Quality Segment

product line

PRECISIO® Kinase

assay

≥70% (SDS-PAGE)

form

buffered aqueous glycerol solution

specific activity

74-102 nmol/min·mg

mol wt

~72 kDa

UniProt accession no.

shipped in

dry ice

storage temp.

−70°C

Gene Information

human ... EPHA2(1969)

General description

EPHA2 (ephrin receptor A2) belongs to the Eph family of receptor tyrosine kinases. It is a type I transmembrane protein, and its exoplasmic domain consists of a ligand binding domain in its N-terminal, a cysteine-rich domain, and two fibronectin type III repeats. Its cytoplasmic domain contains a juxtamembrane region, a tyrosine kinase domain, a SAM (sterile-α-motif) motif, and a PDZ-binding domain.

Biochem/physiol Actions

EPHA2 binds to the ephrin-A ligand and has diverse cellular function. EPHA2 has been shown to be an oncoprotein of importance in a range of cancers. EPHA2 is overexpressed in several human cancer types and promotes malignancy through a mechanism involving RhoA-dependent destabilization of adherens junctions. EPHA2 overexpression induces a FAK-dependent increase in MMP-2 expression and invasiveness and this process can be reversed by ligation of EPHA2.

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, with 150 mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.

Legal Information

PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
WH0001969M1MABS2026SAB5700481
description

PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution

description

clone 6F8, purified immunoglobulin, buffered aqueous solution

description

clone F2-27, from mouse

description

-

assay

≥70% (SDS-PAGE)

assay

-

assay

-

assay

-

Gene Information

human ... EPHA2(1969)

Gene Information

human ... EPHA2(1969)

Gene Information

human ... EPHA2(1969)

Gene Information

human ... EPHA2(1969)

specific activity

74-102 nmol/min·mg

specific activity

-

specific activity

-

specific activity

-

recombinant

expressed in baculovirus infected Sf9 cells

recombinant

-

recombinant

-

recombinant

-

form

buffered aqueous glycerol solution

form

buffered aqueous solution

form

-

form

buffered aqueous solution

shipped in

dry ice

shipped in

dry ice

shipped in

-

shipped in

wet ice


Classe di stoccaggio

10 - Combustible liquids

Che succede?

WGK 1

Punto di infiammabilità (°F)

Not applicable

Punto di infiammabilità (°C)

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti




Domande

Recensioni

Nessuna valutazione

Filtri attivi